지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.5
- 수록면
- 138 - 145 (8page)
이용수
초록· 키워드
오류제보하기
Objective: This study identified the effects of Korean medicine treatment on a patient with metabolic dysfunction-associated fatty liver disease (MAFLD).
Methods: A 43-year-old man with MAFLD was treated with Saenggangunbi-tang with regular exercise from August 13, 2022, to December 24, 2022, to reduce fatigue and dyspepsia and to improve laboratory findings, such as liver enzymes and lipid profiles. We observed changes in symptoms and laboratory findings during the approximately four-month treatment.
Results: Treatment with Saenggangunbi-tang resulted in decreased serum levels of liver enzymes, triglycerides, hepatic steatosis index scores, and clinical symptoms. During the treatment, the patient performed regular exercise; however, there was no significant change in body weight until the end of the study.
Conclusion: This study suggests the availability of Saenggangunbi-tang as a therapeutic option for managing MAFLD patients.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
비만과 이상지질혈증을 동반한 비알코올 지방간질환 환자 치험 1례
대한한방내과학회지
2022 .05
-
철 킬레이트화 치료를 중단한 철과잉증 환자의 생간건비탕을 사용한 치험 1례
대한한방내과학회지
2023 .05
-
고중성지방혈증을 동반한 지방간 환자 치험 1례
대한한방내과학회지
2021 .01
-
상세불명의 비대상성 간경변증 환자 치험 1례
대한한방내과학회지
2020 .01
-
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
Diabetes and Metabolism Journal
2023 .03
-
MAFLD: How is it different from NAFLD?
Clinical and Molecular Hepatology
2023 .02
-
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Clinical and Molecular Hepatology
2024 .01
-
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Clinical and Molecular Hepatology
2021 .01
-
대사증후군을 동반한 비알코올성 지방간염 치험 1례
대한한방내과학회지
2017 .01
-
Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
Diabetes and Metabolism Journal
2024 .09
-
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Clinical and Molecular Hepatology
2022 .04
-
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
Gut and Liver
2022 .09
-
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
Gut and Liver
2021 .01
-
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Clinical and Molecular Hepatology
2023 .04
-
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Clinical and Molecular Hepatology
2024 .07
-
Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease in Korean air force army inclusive of pilots: 2020-2022
항공우주의학 학술대회
2024 .05
-
비알코올성 지방간 환자의 간기능 개선
대한한방내과학회지
2020 .01
-
Atorvastatin이 주요 원인으로 추정되는 간 기능 장애에 대한 생간건비탕 가미방 치험 1례
대한한방내과학회지
2017 .01
-
피로감을 주증으로 입원한 청소년 비알코올성 지방간질환(NAFLD) 환자 치험 1례
대한한방내과학회지
2016 .01
-
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
이 논문의 저자 정보
최근 본 자료
댓글(0)
0